Steven E. Schild

39.5k total citations · 5 hit papers
637 papers, 21.9k citations indexed

About

Steven E. Schild is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Steven E. Schild has authored 637 papers receiving a total of 21.9k indexed citations (citations by other indexed papers that have themselves been cited), including 402 papers in Pulmonary and Respiratory Medicine, 245 papers in Oncology and 209 papers in Surgery. Recurrent topics in Steven E. Schild's work include Brain Metastases and Treatment (164 papers), Management of metastatic bone disease (124 papers) and Lung Cancer Research Studies (120 papers). Steven E. Schild is often cited by papers focused on Brain Metastases and Treatment (164 papers), Management of metastatic bone disease (124 papers) and Lung Cancer Research Studies (120 papers). Steven E. Schild collaborates with scholars based in United States, Germany and Netherlands. Steven E. Schild's co-authors include Alex A. Adjei, Dirk Rades, Julian R. Molina, Ping Yang, Stephen D. Cassivi, William W. Wong, Theo Veninga, Juergen Dunst, James R. Jett and Volker Rudat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Steven E. Schild

626 papers receiving 21.5k citations

Hit Papers

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, T... 2008 2026 2014 2020 2008 2008 2016 2019 2015 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
    2008 2.5k citations Steven E. Schild, Alex A. Adjei et al. profile →
  2. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
    2008 2.3k citations Steven E. Schild, Alex A. Adjei et al. profile →
  3. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
    2016 528 citations Stephen G. Chun, Chen Hu et al. Journal of Clinical Oncology profile →
  4. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
    2019 352 citations Jeffrey D. Bradley, Chen Hu et al. Journal of Clinical Oncology profile →
  5. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
    2015 302 citations Chen Hu, Steven E. Schild et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. Schild United States 66 12.1k 8.0k 4.9k 3.6k 3.1k 637 21.9k
Quynh‐Thu Le United States 79 7.0k 0.6× 7.8k 1.0× 5.8k 1.2× 6.7k 1.9× 3.0k 1.0× 461 25.4k
Eli Glatstein United States 79 10.8k 0.9× 7.3k 0.9× 3.8k 0.8× 1.8k 0.5× 1.1k 0.4× 357 20.4k
M. van Glabbeke Belgium 65 18.4k 1.5× 15.5k 1.9× 9.7k 2.0× 4.5k 1.3× 870 0.3× 198 36.0k
Rodney J. Hicks Australia 78 8.5k 0.7× 7.7k 1.0× 2.9k 0.6× 2.0k 0.6× 1.6k 0.5× 602 23.8k
M. Bolla France 50 16.6k 1.4× 4.6k 0.6× 5.1k 1.0× 1.7k 0.5× 3.3k 1.0× 231 22.9k
Everett E. Vokes United States 95 15.5k 1.3× 19.2k 2.4× 7.6k 1.5× 9.6k 2.7× 965 0.3× 774 36.3k
Albert C. Koong United States 74 4.6k 0.4× 6.2k 0.8× 2.7k 0.6× 5.4k 1.5× 3.3k 1.0× 379 18.3k
Timothy J. Kinsella United States 60 5.6k 0.5× 4.6k 0.6× 2.2k 0.4× 3.7k 1.0× 1.1k 0.4× 301 12.7k
Theodore L. Phillips United States 66 8.2k 0.7× 4.7k 0.6× 3.7k 0.7× 1.4k 0.4× 2.2k 0.7× 310 16.4k
Paul M. Harari United States 60 7.2k 0.6× 8.6k 1.1× 4.0k 0.8× 4.7k 1.3× 1.8k 0.6× 303 18.1k

Countries citing papers authored by Steven E. Schild

Since Specialization
Citations

This map shows the geographic impact of Steven E. Schild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Schild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Schild more than expected).

Fields of papers citing papers by Steven E. Schild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Schild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Schild. The network helps show where Steven E. Schild may publish in the future.

Co-authorship network of co-authors of Steven E. Schild

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Schild. A scholar is included among the top collaborators of Steven E. Schild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Schild. Steven E. Schild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chun, Stephen G., Chen Hu, Ritsuko Komaki, et al.. (2024). Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer. JAMA Oncology. 10(8). 1111–1111. 10 indexed citations
2.
Rades, Dirk, et al.. (2023). Comparison of Three Survival Scores in a Series of Patients ≥80 Years of Age Irradiated for Bone Metastases. Anticancer Research. 43(2). 801–807. 1 indexed citations
3.
Rades, Dirk, et al.. (2023). Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer. Anticancer Research. 43(2). 823–830. 5 indexed citations
4.
Rades, Dirk, et al.. (2023). Early Identification of Pneumonitis in Patients Irradiated for Lung Cancer—Final Results of the PARALUC Trial. Cancers. 15(2). 326–326. 7 indexed citations
5.
Soror, Tamer, et al.. (2023). Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck. Anticancer Research. 43(2). 795–800. 7 indexed citations
6.
Rades, Dirk, Jon Cacicedo, Darejan Lomidze, et al.. (2022). A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression. Practical Radiation Oncology. 12(4). 354–362. 6 indexed citations
7.
Vargas, Carlos, R.S. Bhangoo, William W. Wong, et al.. (2021). Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT). International Journal of Radiation Oncology*Biology*Physics. 110(4). 1189–1199. 27 indexed citations
8.
Rades, Dirk, et al.. (2021). A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme. Anticancer Research. 41(1). 379–384. 3 indexed citations
9.
Yu, Nathan Y., et al.. (2021). Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations. Journal of Thoracic Disease. 13(2). 1270–1285. 7 indexed citations
10.
11.
12.
Janssen, Stefan, et al.. (2019). A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort. Radiology and Oncology. 53(2). 219–224. 6 indexed citations
13.
14.
Waddle, Mark R., Terence T. Sio, Holly K. Van Houten, et al.. (2017). Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients. International Journal of Radiation Oncology*Biology*Physics. 99(5). 1078–1082. 17 indexed citations
15.
Janssen, Stefan, et al.. (2017). A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder. In Vivo. 31(3). 435–438. 2 indexed citations
16.
Heckman, Michael G., Alexander S. Parker, Kevin J. Wu, et al.. (2012). Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. The Prostate. 72(16). 1757–1766. 7 indexed citations
17.
Rades, Dirk, Stefan Huttenlocher, Juergen Dunst, et al.. (2010). Matched Pair Analysis Comparing Surgery Followed By Radiotherapy and Radiotherapy Alone for Metastatic Spinal Cord Compression. Journal of Clinical Oncology. 28(22). 3597–3604. 113 indexed citations
18.
König, Inke R., Dirk Rades, F. Noack, et al.. (2009). p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction. Cancer Investigation. 27(1). 96–104. 5 indexed citations
19.
Rades, Dirk, Juergen Dunst, & Steven E. Schild. (2007). The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer. 112(1). 157–161. 115 indexed citations
20.
Jatoi, Aminah, Shauna L. Hillman, Philip J. Stella, et al.. (2005). Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group. Journal of Clinical Oncology. 23(36). 9113–9119. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quynh‐Thu Le Breakdown of academic impact, for papers by Eli Glatstein Breakdown of academic impact, for papers by M. van Glabbeke Breakdown of academic impact, for papers by Rodney J. Hicks Breakdown of academic impact, for papers by M. Bolla Breakdown of academic impact, for papers by Everett E. Vokes Breakdown of academic impact, for papers by Albert C. Koong Breakdown of academic impact, for papers by Timothy J. Kinsella Breakdown of academic impact, for papers by Theodore L. Phillips Breakdown of academic impact, for papers by Paul M. Harari
Rankless by CCL
2026